Phase I/II trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF fusion/duplication positive or NF1-associated recurrent or progressive gliomas in children and young adults
![](/Content/images/study-category-images/anschutz-campus.jpg)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Kathleen Dorris](https://som.ucdenver.edu/FIMS/Content/faculty/21799/CU-Doctors-21799.jpg)
Kathleen Dorris
Study ID
Protocol Number: 20-0535
More information available at ClinicalTrials.gov: NCT04201457
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers